Terazosin Capsule
Product Images NDC 71335-3131

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71335-3131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Figure 01)

Image Description (Figure 01)
This is a comparison of the mean change in total symptom score from baseline between placebo and terazosin in Study 1. Additionally, it includes the mean increase in peak flow rate (in mL/sec) from baseline for terazosin and placebo over a period of three months.*
FDA Label Image

Image Description (Figure 02)

Image Description (Figure 02)
This is a description of the mean change in total symptom score from baseline in a long-term, open-label, non-placebo controlled study. The study had a total of 494 participants and assessed changes at different time points over a 30-month period.*
FDA Label Image

Image Description (Figure 03)

Image Description (Figure 03)
This is a graph showing the mean change in peak flow rate from the baseline in a long-term, open-label, non-placebo controlled study with a total of 494 participants. The graph spans over a period of 30 months, displaying the month increments on the x-axis and the mean change from the baseline in mL/sec on the y-axis.*
FDA Label Image

Label (Lbl713353131)

Label (Lbl713353131)
Each capsule of Terazosin contains 5 mg of Terazosin hydrochloride. The usual dosage can be found by scanning the package insert QR code. Pharmacists are reminded to dispense with the patient information sheet and to store the capsules in a tight, light-resistant container at 20°C to 25°C. The medication should be protected from light and moisture. *
FDA Label Image

Image Description (Structure001)

Image Description (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.